A long criticised study on antidepressant use in adolescents has been flagged with an “expression of concern” by a leading ...

GSK raised its 2025 sales and earnings forecasts on Wednesday as its speciality HIV and cancer drugs posted double digit ...

GSK's London-listed shares fell nearly 2% on Friday after the U.S. Food and Drug Administration approved only one of two ...

The U.S. Food and Drug Administration has approved British drugmaker GSK's blood cancer drug, Blenrep, in one combination ...

New Jersey orthopedic surgeon Michael Meese, MD, has sued a local school district for which he served as medical director for ...

Now it's GSK plc's turn (NYSE:GSK) (OTCPK:GLAXF). Since the publication of my article "GSK's Strong Performance: Why I'm Upgrading to 'Strong Buy'" on February 18, GSK's stock price has risen 20.3%.

GSK plc (NYSE: GSK) appointed Luke Miels as the CEO Designate of GSK. He will assume full responsibility as CEO and join the Board on January 1, 2026. He joined GSK in 2017 and is currently Chief ...

Shares of GSK rallied on Monday after the U.K. pharmaceutical giant turned to an insider to become its next CEO. Luke Miels, chief commercial officer, will take the reigns on Jan. 1 from Emma Walmsley ...

GSK CEO Emma Walmsley will be stepping aside after nine years. Shares of GSK rallied on Monday after the U.K. pharmaceutical giant turned to an insider to become its next CEO. Luke Miels, chief ...

GSK GSK-0.14%decrease; red down pointing triangle said Chief Executive Emma Walmsley would step down and be succeeded by commercial chief Luke Miels, as the drugmaker works to replenish its product ...

While the United Kingdom feted President Trump in his second state visit, GSK said Wednesday it will spend $30 billion over the next five years to build new manufacturing and research facilities ...

(RTTNews) - British drug major GSK plc (GSK, GSK.L) announced Wednesday its plans to invest $30 billion across the United States in research and development and supply chain infrastructure over the ...